Increased evidence for use of chemotherapy in pregnancy

The Lancet Oncology

Volumn 13, Issue 9, 2012, Pages 852-854

  Mir, Olivier ^a,b   Berveiller, Paul ^a  

^a Cancer Associated with Pregnancy Network   (France)

^b Université Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; PACLITAXEL;

BIRTH WEIGHT; BODY SURFACE; BODY WEIGHT; BREAST CANCER; CANCER INCIDENCE; CANCER PROGNOSIS; CHEMOSENSITIVITY; DISEASE ASSOCIATION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FETAL WELL BEING; HUMAN; INFECTION; LETTER; NEUTROPENIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA;

ABNORMALITIES, DRUG-INDUCED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIRTH WEIGHT; BREAST NEOPLASMS; FEMALE; HUMANS; INFANT, NEWBORN, DISEASES; MALE; PREGNANCY; PREGNANCY OUTCOME;

EID: 84865552287     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70331-5     Document Type: Letter

References (13)

1. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006, 107:1219-1226.
2. Loibl S, Han S, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 2012, published online Aug 16. http://dx.doi.org/10.1016/S1470-2045(12)70261-9.
3. Rouzier R, Werkoff G, Uzan C, et al. Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting. Ann Oncol 2011, 22:1582-1587.
4. Mir O, Berveiller P, Rouzier R, Goffinet F, Goldwasser F, Treluyer JM Chemotherapy for breast cancer during pregnancy: is epirubicin safe?. Ann Oncol 2008, 19:1814-1815.
5. Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 2011, 46:3158-3168.
6. Anderson GD Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005, 44:989-1008.
7. Germann N, Goffinet F, Goldwasser F Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004, 15:146-150.
8. Lycette JL, Dul CL, Munar M, et al. Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report. Clin Breast Cancer 2006, 7:342-344.
9. Marnitz S, Kohler C, Oppelt P, et al. Cisplatin application in pregnancy: first in vivo analysis of 7 patients. Oncology 2011, 79:72-77.
10. Mir O, Berrada N, Domont J, et al. Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy. Cancer Chemother Pharmacol 2012, 69:357-367.
11. Van Calsteren K, Verbesselt R, Ottevanger N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand 2010, 89:1338-1345.
12. Peccatori FA, Azim HA, Scarfone G, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat 2009, 115:591-594.
13. Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 2012, 13:256-264.